Great news about cancer drug, Opdivo, which successfully ended its lung cancer clinical trial two years ahead of schedule. We as a lung cancer community are incredibly excited about the activity of immunotherapy in various aspects of the disease, said Pasi Janne, Free to Breathe Scientific Executive Committee member. Read more: usatoday/story/news/health/2015/01/12/new-drug-opdivo-successful-in-lung-cancer-trial/21659553/
Posted on: Thu, 15 Jan 2015 20:34:00 +0000
Trending Topics
Recently Viewed Topics
© 2015